Treatment of defects of humoral immunity.
D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology; D004341:Drug Evaluation; D005341:Fibrinolysin / Q000627:therapeutic use; D006801:Humans; D007070:Immunoglobulin A / Q000008:administration & dosage; D007074:Immunoglobulin G / Q000008:administration & dosage; D007153:Immunologic Deficiency Syndromes / Q000276:immunology / Q000628:therapy*; D007167:Immunotherapy / Q000009:adverse effects; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D012712:Serum Globulins / Q000008:administration & dosage; D013329:Structure-Activity Relationship
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D012712:Serum Globulins; D005341:Fibrinolysin